These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 29522647)
1. Preventability of serious thromboembolic and bleeding events related to the use of oral anticoagulants: a prospective study. Sennesael AL; Larock AS; Devalet B; Mathieux V; Verschuren F; Muschart X; Dalleur O; Dogné JM; Spinewine A Br J Clin Pharmacol; 2018 Jul; 84(7):1544-1556. PubMed ID: 29522647 [TBL] [Abstract][Full Text] [Related]
2. What are the Characteristics of Patients Experiencing Adverse Drug Reactions to Oral Anticogulants and How Can Such Reactions be Prevented? Spada G; Vighi GV; Pagani S; Vighi GD; Venegoni M; Ruocco M Curr Drug Saf; 2020; 15(1):38-44. PubMed ID: 31580253 [TBL] [Abstract][Full Text] [Related]
3. Clinical Benefit of Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves. Russo V; Carbone A; Attena E; Rago A; Mazzone C; Proietti R; Parisi V; Scotti A; Nigro G; Golino P; D'Onofrio A Clin Ther; 2019 Dec; 41(12):2549-2557. PubMed ID: 31735436 [TBL] [Abstract][Full Text] [Related]
4. Adverse drug reactions with oral anticoagulants: data from sicilian spontaneous reporting system database. Barbieri MA; Cutroneo PM; Baratelli C; Cicala G; Battaglia A; Santoro V; Andò G; Spina E J Clin Pharm Ther; 2021 Aug; 46(4):1027-1040. PubMed ID: 33646603 [TBL] [Abstract][Full Text] [Related]
5. Clinical profile of direct oral anticoagulants versus vitamin K anticoagulants in octogenarians with atrial fibrillation: a multicentre propensity score matched real-world cohort study. Russo V; Attena E; Di Maio M; Mazzone C; Carbone A; Parisi V; Rago A; D'Onofrio A; Golino P; Nigro G J Thromb Thrombolysis; 2020 Jan; 49(1):42-53. PubMed ID: 31385163 [TBL] [Abstract][Full Text] [Related]
6. Major bleeding with vitamin K antagonists or direct oral anticoagulants in real-life. Becattini C; Franco L; Beyer-Westendorf J; Masotti L; Nitti C; Vanni S; Manina G; Cattinelli S; Cappelli R; Sbrojavacca R; Pomero F; Marten S; Agnelli G Int J Cardiol; 2017 Jan; 227():261-266. PubMed ID: 27843050 [TBL] [Abstract][Full Text] [Related]
7. Periprocedural anticoagulation during left atrial ablation: interrupted and uninterrupted vitamin K-antagonists or uninterrupted novel anticoagulants. Brinkmeier-Theofanopoulou M; Tzamalis P; Wehrkamp-Richter S; Radzewitz A; Merkel M; Schymik G; van Mark G; Bramlage P; Schmitt C; Luik A BMC Cardiovasc Disord; 2018 Apr; 18(1):71. PubMed ID: 29703158 [TBL] [Abstract][Full Text] [Related]
8. Impaired kidney function at ED admission: a comparison of bleeding complications of patients with different oral anticoagulants. Müller M; Traschitzger M; Nagler M; Arampatzis S; Exadaktylos AK; Sauter TC BMC Emerg Med; 2021 Sep; 21(1):105. PubMed ID: 34536992 [TBL] [Abstract][Full Text] [Related]
9. Anticoagulant-related gastrointestinal bleeding: a real-life data analysis on bleeding profiles, frequency and etiology of patients receiving direct oral anticoagulants versus vitamin K antagonists. Albrecht H; Maass LS; Hagel AF; Neurath MF; Konturek PC; Raithel M J Physiol Pharmacol; 2019 Dec; 70(6):. PubMed ID: 32203937 [TBL] [Abstract][Full Text] [Related]
10. Retrospective analysis of gastrointestinal bleedings with direct oral anticoagulants reported to EudraVigilance. Moudallel S; van den Eynde C; Malý J; Rydant S; Steurbaut S Naunyn Schmiedebergs Arch Pharmacol; 2023 Jun; 396(6):1143-1153. PubMed ID: 36656352 [TBL] [Abstract][Full Text] [Related]
11. Comparison of Treatment Persistence with Dabigatran or Rivaroxaban versus Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients: A Competing Risk Analysis in the French National Health Care Databases. Maura G; Billionnet C; Alla F; Gagne JJ; Pariente A Pharmacotherapy; 2018 Jan; 38(1):6-18. PubMed ID: 29028119 [TBL] [Abstract][Full Text] [Related]
12. Adaptation and validation of an adverse drug reaction preventability score for bleeding due to vitamin K antagonists. Liabeuf S; Masmoudi K; Scailteux LM; Moragny J; Masson H; Brnet-Dufour V; Andrejak M; Gras-Champel V Medicine (Baltimore); 2016 Sep; 95(39):e4762. PubMed ID: 27684801 [TBL] [Abstract][Full Text] [Related]
13. Bleeding and thrombotic complications during treatment with direct oral anticoagulants or vitamin K antagonists in venous thromboembolic patients included in the prospective, observational START2-register. Palareti G; Antonucci E; Legnani C; Mastroiacovo D; Poli D; Prandoni P; Tosetto A; Pengo V; Testa S; Ageno W; BMJ Open; 2020 Nov; 10(11):e040449. PubMed ID: 33247017 [TBL] [Abstract][Full Text] [Related]
14. Lower Major Bleeding Rates with Direct Oral Anticoagulants in Catheter Ablation of Atrial Fibrillation: an Updated Meta-analysis of Randomized Controlled Studies. Brunetti ND; Tricarico L; Tilz RR; Heeger CH; De Gennaro L; Correale M; Ieva R; Di Biase M; Rillig A; Metzner A; Santoro F Cardiovasc Drugs Ther; 2020 Apr; 34(2):209-214. PubMed ID: 32080786 [TBL] [Abstract][Full Text] [Related]
15. Risk of major bleeding and stroke associated with the use of vitamin K antagonists, nonvitamin K antagonist oral anticoagulants and aspirin in patients with atrial fibrillation: a cohort study. Gieling EM; van den Ham HA; van Onzenoort H; Bos J; Kramers C; de Boer A; de Vries F; Burden AM Br J Clin Pharmacol; 2017 Aug; 83(8):1844-1859. PubMed ID: 28205318 [TBL] [Abstract][Full Text] [Related]
16. Direct oral anticoagulants versus vitamin K antagonists in real-world patients with nonvalvular atrial fibrillation. The FANTASIIA study. Anguita Sánchez M; Bertomeu Martínez V; Ruiz Ortiz M; Cequier Fillat Á; Roldán Rabadán I; Muñiz García J; Badimón Maestro L; Esteve Pastor MA; Marín Ortuño F; Rev Esp Cardiol (Engl Ed); 2020 Jan; 73(1):14-20. PubMed ID: 31160265 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Nonvitamin K Oral Anticoagulants in Patients with Atrial Fibrillation and Cancer: A Study-Level Meta-Analysis. Cavallari I; Verolino G; Romano S; Patti G Thromb Haemost; 2020 Feb; 120(2):314-321. PubMed ID: 31785599 [TBL] [Abstract][Full Text] [Related]
18. Falls in ED patients: do elderly patients on direct oral anticoagulants bleed less than those on vitamin K antagonists? Müller M; Chanias I; Nagler M; Exadaktylos AK; Sauter TC Scand J Trauma Resusc Emerg Med; 2021 Apr; 29(1):56. PubMed ID: 33823884 [TBL] [Abstract][Full Text] [Related]
19. Burden of Inappropriate Prescription of Direct Oral Anticoagulants at Hospital Admission and Discharge in the Elderly: A Prospective Observational Multicenter Study. Bruneau A; Schwab C; Anfosso M; Fernandez C; Hindlet P Drugs Aging; 2019 Nov; 36(11):1047-1055. PubMed ID: 31486994 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Direct Oral Anticoagulants in Kidney Transplantation: A Single-center Pilot Experience. Leon J; Sabbah L; Aubert O; Anglicheau D; Delavenne X; Zuber J; Amrouche L; Scemla A; Giura G; Divard G; Legendre C; Sberro-Soussan R Transplantation; 2020 Dec; 104(12):2625-2631. PubMed ID: 32044892 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]